AI-powered search
Try Polaris, our new AI-powered search!
hero
Topical Conversations
Tune in to hear insights and updates on some of the hot topics in dermatology. In this series, we showcase expert updates on featured conditions, KOL discussions, and much more!
GPP in Every Patient: Understanding Its Diverse Presentations for Better Treatment Outcomes

Generalized Pustular Psoriasis (GPP)

GPP in Every Patient: Understanding Its Diverse Presentations for Better Treatment Outcomes

Featuring Ronald Vender, MD, FRCPC | Raj Chovatiya, MD, PhD, MSCI

Overcoming Barriers to Systemic Therapy in Atopic Dermatitis

Atopic Dermatitis

Overcoming Barriers to Systemic Therapy in Atopic Dermatitis

Featuring Brad Glick, DO, MPH | James Del Rosso, DO

Refining Sentinel Lymph Node Biopsy Decisions: The Role of GEP Testing in Melanoma Care

Cutaneous Melanoma

Refining Sentinel Lymph Node Biopsy Decisions: The Role of GEP Testing in Melanoma Care

Featuring Aaron Farberg, MD | David Cotter, MD, PhD

Type 2 Inflammation in Skin Conditions: A Clinical Perspective

Atopic Dermatitis

Type 2 Inflammation in Skin Conditions: A Clinical Perspective

Featuring Michael Cameron, MD

Shifting the Paradigm: Chronic Management of Generalized Pustular Psoriasis

Generalized Pustular Psoriasis (GPP)

Shifting the Paradigm: Chronic Management of Generalized Pustular Psoriasis

Featuring Aaron Farberg, MD | Neal Bhatia, MD

Treating Atopic Dermatitis Early: Can We Impact the Atopic March?

Atopic Dermatitis

Treating Atopic Dermatitis Early: Can We Impact the Atopic March?

Featuring Lisa Swanson, MD | James Del Rosso, DO

Exploring Emerging Dermatology Devices and Treatments in 2025

Acne

Exploring Emerging Dermatology Devices and Treatments in 2025

Featuring Stephen Lewellis, MD, PhD, FAAD

Examining the Role of GLP-1 Receptor Agonists in Treating Inflammatory Skin Diseases

Psoriasis

Examining the Role of GLP-1 Receptor Agonists in Treating Inflammatory Skin Diseases

Featuring Michael Cameron, MD | James Allred, MD

Psoriasis and IL-17 Inhibitors: Balancing Efficacy and Safety with Ixekizumab

Psoriasis

Psoriasis and IL-17 Inhibitors: Balancing Efficacy and Safety with Ixekizumab

Featuring Brad Glick, DO, MPH | Jason Hawkes, MD, MS

National Healthy Skin Month: Supporting Healthy Skin in Babies

Pediatric Dermatology

National Healthy Skin Month: Supporting Healthy Skin in Babies

Featuring Lisa Swanson, MD

Expanding Treatment Options for Actinic Keratosis: Tirbanibulin

Actinic Keratoses

Expanding Treatment Options for Actinic Keratosis: Tirbanibulin

Featuring Neal Bhatia, MD | Naiem Issa, MD, PhD, FAAD

Optimizing Long-Term Treatment of Moderate Atopic Dermatitis with Dupilumab

Atopic Dermatitis

Optimizing Long-Term Treatment of Moderate Atopic Dermatitis with Dupilumab

Featuring James Del Rosso, DO | Alexandra Golant, MD

The Role of Ixekizumab in Pediatric Psoriasis Management

Psoriasis

The Role of Ixekizumab in Pediatric Psoriasis Management

Featuring Lisa Swanson, MD | Karan Lal, DO, MS, FAAD

The Role of the OX40/OX40 Ligand Pathway in Atopic Dermatitis

Atopic Dermatitis

The Role of the OX40/OX40 Ligand Pathway in Atopic Dermatitis

Featuring James Del Rosso, DO

Approaching Systemic Therapies for Moderate Atopic Dermatitis

Atopic Dermatitis

Approaching Systemic Therapies for Moderate Atopic Dermatitis

Featuring Marc Serota, MD | Heather Gates, PA-C, MPAS, DFAAPA

24 of 81